COMP <GO>
SNWV vs MRK // OPERATING MARGIN
SANUWAVE Health Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: SNWV 7
— MRK 4
▲ OPERATING MARGIN LEADER: MRK
LAST: $5.15 (-2.28%) • MKT CAP: $45.3M
operating-margins
11.20%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNWV | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.10% | 74.80% | +2.30 | SNWV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 67.30% | 20.70% | +46.60 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.5x | 15.3x | -7.80 | SNWV | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 3.42% | +0.85 | SNWV | /fcf-yield <GO> |
| Operating Margin ACTIVE | 11.20% | 34.30% | -23.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 26.80% | 28.10% | -1.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 36.30% | 1.30% | +35.00 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 51.7 | +1.40 | SNWV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.5x | 18.4x | -14.90 | SNWV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.3M | $361.02B | -$360.98B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNWV REV | MRK REV | SNWV GROSS % | MRK GROSS % | SNWV FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.1M | $65.01B | 77.1% | 74.8% | $1.9M | $12.36B |
| FY 2024 | $32.3M | $64.17B | 75.9% | 76.3% | $2.0M | $18.10B |
| FY 2023 | $19.3M | $60.12B | — | — | -$4.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
MRK // BETA 0.92